The organizations have been working together since
Robust real-world evidence is becoming increasingly important for pharma and medical device development. As an example, with the passage of the Inflation Reduction Act (IRA) in
'As life sciences and medical device companies continue to bridge the gap between medical solutions development and real-world application, leveraging real-world data for real-world evidence generation has emerged as a game changer,' said
Today, a clinical trial for a chronic condition is utilizing Datavant to link clinical trial patient data and PHD data to understand the participants' complete patient journey. By uniting clinical trial data with real-world data contained in the PHD, researchers are gaining insight into medication history, which can be difficult to collect, as well as the ability to follow the patients forward after the trial has ended, when oftentimes patients are lost. The real-world evidence generated from the linked data can be used to assess important long-term health outcomes outside of the clinical trial, improve drug safety and efficacy, and empower the healthcare industry to treat chronic care conditions more effectively.
In another clinical trial, a sponsor is building a real-world evidence control arm using PAS' real-world data connected by Datavant at the patient level while preserving patient privacy. Utilizing real-world data/real-world evidence derived from patients on a standard of care may eliminate the need for researchers to construct a separate control arm, which can decrease the duration and cost of the clinical trial. The real-world evidence control arm is also helping to improve the patient experience and outcomes by enabling all study participants to partake in the treatment and its potential benefits rather than a placebo, thereby increasing their access to medical care.
In addition to these active trials, PAS' linkable datasets are being utilized by life sciences and medical device companies and health systems to find diverse trial candidates and identify trial sites - both of which have a critical impact on bringing new solutions to market.
'Ever since launching our trial tokenization offering in 2019, Datavant has held that linking clinical trial data and real-world data has incredible promise to accelerate drug development, improve the safety and efficacy of treatments, and lead to better patient outcomes,' said
About PINC AI Applied Sciences (PAS)
PAS is a trusted leader in accelerating healthcare improvement through services, data and scalable solutions, spanning the continuum of care and enabling sustainable innovation and rigorous research. These services and real-world data are valuable resources for the pharmaceutical, device and diagnostic industries, academia, federal and national healthcare agencies, as well as hospitals and health systems. Since 2000, PAS researchers have produced more than 1,000 publications which appear in 264 scholarly, peer-reviewed journals, covering a wide variety of topics, and conduct population-based analyses of drugs, devices, treatments, disease states, epidemiology, resource utilization, healthcare economics and clinical outcomes.
About the PINC AI Platform
PINC AI is the technology and services platform of
About Datavant
Datavant's mission is to make the world's health data secure, accessible, and usable. Datavant is a data logistics company for healthcare whose products and solutions enable organizations to move and connect data securely.
Through proprietary technology, the world's most robust healthcare network, and value-added services we protect, connect, and deliver the world's health data. Datavant enables more than 60 million healthcare records to move between thousands of organizations, more than 70,000 hospitals and clinics, 70 percent of the 100 largest health systems, and an ecosystem of 500+ real-world data partners.
About Datavant Connect
Datavant Connect is a platform for secure, compliant real-world data connectivity. The platform enables organizations to tokenize data, find and assess potential data partners, and connect datasets at the individual level while preserving patient privacy. The backbone of the platform is tokenization technology that uses personally identifiable information (PII) to create encrypted tokens, which are unique, irreversible, and site-specific keys that can match individual patient records within and across datasets.
Statements made in this release that are not statements of historical or current facts, including but not limited to those related to
Contact:
Email: publicrelations@premierinc.com
Email: pr@datavant.com
(C) 2024 Electronic News Publishing, source